You are here: Industry Insights > brain

News List

What is CNS disease? ChatGPT/PharmaSources
November 08, 2023
Central Nervous System (CNS) disease refers to a broad category of medical conditions that affect the brain and spinal cord, which together comprise the central nervous system.
AHA News: Statistics Report Offers Snapshot of the Nation's Brain Health – And a Guide to Protecting It drugs.com
January 26, 2022
Brain diseases, including Alzheimer's disease and other forms of dementia, are closely connected to heart health.
Keeping Weight Stable Could Help Save Your Brain drugs.com
January 25, 2022
Older adults who maintain a steady weight as they age are less likely to experience rapid cognitive decline...
Researchers identify new genetic clues for ‘silent’ strokes pharmatimes
March 29, 2021
New research has discovered genetic clues in people who have had small, ‘silent’ strokes that could enable the development of new treatments for the condition.
Salbutamol significantly increases cerebral perfusion in proof-of-concept trial europeanpharmaceuticalreview
March 17, 2021
In the Phase I trial, the beta-2 adrenoceptor agonist salbutamol significantly increased cerebral perfusion, a key biomarker in neurodegenerative disease.
Scientists at IIT Madras identify energy deficiency in brain cells as major cause for Parkinson’s Disease expresspharma
March 11, 2021
The novel findings of this research may enhance understanding of the pathophysiology of Parkinson’s Disease and might finally lead to a cure.
Parkinson’s UK invests £1.2m in drug design project pharmatimes
March 10, 2021
Charity organisation Parkinson’s UK has announced it will fund up to £1.2m into a one-year drug design project in partnership with the University of Sheffield.
OncoSynergy Announces First Patient Treated in OS2966 Trial of Recurrent Glioblastoma americanpharmaceuticalreview
March 10, 2021
OncoSynergy announced the first patient was treated in the Company's First-in-Human Phase 1 clinical trial evaluating OS2966 for the treatment of recurrent glioblastoma at Moffitt Cancer Center in Tampa, Florida.
Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials prnasia
February 10, 2021
Alterity Therapeutics has announced the award of a grant from The Michael J. Fox Foundation for Parkinson's Research to determine optimal dosing of its lead drug candidate ATH434 for Parkinson's disease (PD) based on imaging of brain iron.
New system could deliver schizophrenia medicine directly to brain europeanpharmaceuticalreview
January 20, 2021
A team has created a nasal spray as a drug delivery system to get schizophrenia medication directly to the brain.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 13 14 Next page